These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15480176)

  • 21. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
    Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
    Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.
    Geddes CC; Gunson R; Mazonakis E; Wan R; Thomson L; Clancy M; Carman WF
    Transpl Infect Dis; 2011 Apr; 13(2):109-16. PubMed ID: 21457419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BK virus nephropathy in simultaneous pancreas kidney transplant: a potentially preventable cause of kidney allograft loss.
    Mujtaba M; Fridell J; Sharfuddin A; Kandula P; Yaqub MS; Phillips CL; Mishler D; Taber T
    Clin Transplant; 2012; 26(2):E87-93. PubMed ID: 22448973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
    Guasch A; Roy-Chaudhury P; Woodle ES; Fitzsimmons W; Holman J; First MR;
    Transplantation; 2010 Oct; 90(8):891-7. PubMed ID: 20811320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
    Ramos E; Drachenberg CB; Portocarrero M; Wali R; Klassen DK; Fink JC; Farney A; Hirsch H; Papadimitriou JC; Cangro CB; Weir MR; Bartlett ST
    Clin Transpl; 2002; ():143-53. PubMed ID: 12971444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyomavirus nephropathy after renal transplantation: a single centre experience.
    Kim HC; Hwang EA; Han SY; Park SB; Park KK
    Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual positivity of donor and recipient plasma for BK virus confers a high risk for development of bk nephropathy in renal allograft.
    Thakur R; Joshi K; Minz M; Singla A; Nada R; Arora S; Jha V; Sakhuja V
    Transplant Proc; 2012 Apr; 44(3):717-20. PubMed ID: 22483476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
    Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
    Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigen Cw7-mediated protection against polyoma BK virus in renal transplant recipients who received grafts from antigen-positive donors.
    Gheith O; Al-Otaibi T; Zakaria Z; Abdel Halim M; Nampoory N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():383-7. PubMed ID: 25894195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of BK viral load in asymptomatic renal allograft recipients.
    Chan GC; Leung AY; Wong AS; Chan KW; Kwong YL; Lai KN; Tang SC
    Ren Fail; 2012; 34(5):550-4. PubMed ID: 22390257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BK virus associated nephropathy in renal transplantation: where do we stand.
    Gupta A; Gupta P
    Minerva Urol Nefrol; 2011 Jun; 63(2):155-67. PubMed ID: 21623333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for BK polyomavirus nephritis in renal allograft recipients.
    Rocha PN; Plumb TJ; Miller SE; Howell DN; Smith SR
    Clin Transplant; 2004 Aug; 18(4):456-62. PubMed ID: 15233826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring the progress of BK virus associated nephropathy in renal transplant recipients.
    Tong CY; Hilton R; MacMahon EM; Brown L; Pantelidis P; Chrystie IL; Kidd IM; Tungekar MF; Pattison JM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2598-605. PubMed ID: 15292464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy.
    Hirsch HH; Mohaupt M; Klimkait T
    J Infect Dis; 2001 Dec; 184(11):1494-5; author reply 1495-6. PubMed ID: 11709797
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of BK virus nephropathy and cytomegalovirus infection concurrent with plasma cell-rich acute rejection.
    Mafune A; Tanno Y; Yamamoto H; Kobayashi A; Saigawa H; Yokoo T; Hayakawa H; Miyazaki Y; Yokoyama K; Yamaguchi Y; Hosoya T
    Clin Transplant; 2012 Jul; 26 Suppl 24():49-53. PubMed ID: 22747476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.